See every side of every news story
Published loading...Updated

$5 million Fox Foundation grant targets GBA1 Parkinson's research

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded a $5 million grant to Congruence Therapeutics to advance the development of small molecules for Parkinson’s disease associated with mutations in the GBA1 gene. The research grant will support the optimization and clinical development of therapeutic candidates that can enter the brain and enhance the activity of the glucocerebrosidase (GCase) enzyme, which is produced by th…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Parkinson's News Today broke the news in on Tuesday, July 29, 2025.
Sources are mostly out of (0)